Cross-border converter
NACE Rev 2.1 21.10 → NACE-LUX equivalent (Luxembourg)
Cyprus's national activity classification (NACE Rev 2.1) shares its 4-digit backbone with the EU NACE Rev 2.1 standard. We use that backbone to surface the equivalent NACE-LUX subclass(es) used in Luxembourg.
Shared EU parent
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21.10
Manufacture of basic pharmaceutical products
Luxembourg's NACE-LUX does not split EU class 2110 into a national subclass, or its data isn't loaded yet.
About this conversion
NACE Rev 2.1 is the activity classification used in Cyprus. NACE-LUX is the equivalent system in Luxembourg. Both are national implementations of EU NACE Rev 2.1, so any 5th-digit subclass in one system can be traced back to a shared 4-digit EU class — and from there, forward into the other country's subclasses.
This page is generated for the query "NACE Rev 2.1 21.10 to NACE-LUX" and stays in sync with our monthly Market Intelligence sync.